Forte Biosciences Inc (NASDAQ:FBRX) has a beta value of 2.94 and has seen 0.5 million shares traded in the recent trading session. The company, currently valued at $73.26M, closed the recent trade at $11.13 per share which meant it lost -$3.04 on the day or -21.47% during that session. The FBRX stock price is -157.68% off its 52-week high price of $28.68 and 63.07% above the 52-week low of $4.11. If we look at the company’s 10-day average daily trading volume, we find that it stood at 90060.0 shares traded. The 3-month trading volume is 54.74K shares.
The consensus among analysts is that Forte Biosciences Inc (FBRX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -1.18.
Forte Biosciences Inc (NASDAQ:FBRX) trade information
Sporting -21.47% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the FBRX stock price touched $11.13 or saw a rise of 43.3%. Year-to-date, Forte Biosciences Inc shares have moved -8.92%, while the 5-day performance has seen it change -10.11%. Over the past 30 days, the shares of Forte Biosciences Inc (NASDAQ:FBRX) have changed 31.08%. Short interest in the company has seen 0.17 million shares shorted with days to cover at 2.64.
Forte Biosciences Inc (FBRX) estimates and forecasts
The company’s shares have lost -40.36% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 24.08% over the past 5 years. Earnings growth for 2025 is a modest 61.77% while over the next 5 years, the company’s earnings are expected to increase by 41.96%.
FBRX Dividends
Forte Biosciences Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Forte Biosciences Inc (NASDAQ:FBRX)’s Major holders
Insiders own 9.35% of the company shares, while shares held by institutions stand at 80.32% with a share float percentage of 88.60%. Investors are also buoyed by the number of investors in a company, with Forte Biosciences Inc having a total of 36.0 institutions that hold shares in the company. The top two institutional holders are TYBOURNE CAPITAL MANAGEMENT (HK) LTD with over 3.62 million shares worth more than $1.95 million. As of 2024-06-30, TYBOURNE CAPITAL MANAGEMENT (HK) LTD held 7.8653% of shares outstanding.
The other major institutional holder is PERCEPTIVE ADVISORS LLC, with the holding of over 3.27 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.75 million and represent 7.0858% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are ALGER FUNDS-Alger Small Cap Focus Fund and ALGER FUNDS-Alger Health Sciences Fund . As of Jan 31, 2025 , the former fund manager holds about 2.42% shares in the company for having 159.55 shares of worth $1.77 million while later fund manager owns 134.57 shares of worth $1.49 million as of Jan 31, 2025 , which makes it owner of about 2.04% of company’s outstanding stock.
